{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:50:11Z","timestamp":1791946211799,"version":"4.3.4"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04820-2","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:07:11Z","timestamp":1786975631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regenerative strategies for ALS: stem cells and extracellular vesicles"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3653-850X","authenticated-orcid":false,"given":"Trisha","family":"Raghunathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnya","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetham","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-4697","authenticated-orcid":false,"given":"Anandh","family":"Dhanushkodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"4820_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131763","author":"GJM Afonso","year":"2023","unstructured":"Afonso GJM, Cavaleiro C, Valero J, Mota SI, Ferreiro E. Recent advances in extracellular vesicles in amyotrophic lateral sclerosis and emergent perspectives. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12131763.","journal-title":"Cells"},{"key":"4820_CR2","doi-asserted-by":"publisher","first-page":"1655124","DOI":"10.3389\/fneur.2025.1655124","volume":"16","author":"E Aguera-Morales","year":"2025","unstructured":"Aguera-Morales E, Fernandez-Sanchez VE, Navarro-Mascarell G, Cabezas-Rodriguez JA, Pena-Toledo MA, Reyes-Rodriguez V, et al. Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I\/II safety and efficacy clinical trial. Front Neurol. 2025;16:1655124. https:\/\/doi.org\/10.3389\/fneur.2025.1655124.","journal-title":"Front Neurol"},{"issue":"4","key":"4820_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbadis.2014.08.010","volume":"1852","author":"S Ajroud-Driss","year":"2015","unstructured":"Ajroud-Driss S, Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS). Biochim Biophys Acta. 2015;1852(4):679\u201384. https:\/\/doi.org\/10.1016\/j.bbadis.2014.08.010.","journal-title":"Biochim Biophys Acta"},{"key":"4820_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1603752","volume":"13","author":"AA Alhamdi","year":"2025","unstructured":"Alhamdi AA, Mackie S, Trueman RP, Rayner MLD. Pharmacologically targeting Schwann cells to improve regeneration following nerve damage. Front Cell Dev Biol. 2025;13:1603752. https:\/\/doi.org\/10.3389\/fcell.2025.1603752.","journal-title":"Front Cell Dev Biol"},{"key":"4820_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T, Deore SL, Kide AA, Shende BA, Sharma R, Dadarao Chakole R, et al. Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis -an updated review. Mitochondrion. 2023;71:83\u201392. https:\/\/doi.org\/10.1016\/j.mito.2023.05.007.","journal-title":"Mitochondrion"},{"key":"4820_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115587","author":"FJ Arnold","year":"2024","unstructured":"Arnold FJ, Putka AF, Raychaudhuri U, Hsu S, Bedlack RS, Bennett CL, et al. Revisiting glutamate excitotoxicity in amyotrophic lateral sclerosis and age-related neurodegeneration. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25115587.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4820_CR7","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202402853","volume":"7","author":"WH Au","year":"2024","unstructured":"Au WH, Miller-Fleming L, Sanchez-Martinez A, Lee JA, Twyning MJ, Prag HA, et al. Activation of the Keap1\/Nrf2 pathway suppresses mitochondrial dysfunction, oxidative stress, and motor phenotypes in C9orf72 ALS\/FTD models. Life Sci Alliance. 2024;7(9):e202402853. https:\/\/doi.org\/10.26508\/lsa.202402853.","journal-title":"Life Sci Alliance"},{"key":"4820_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177187","volume":"987","author":"A Bajpai","year":"2025","unstructured":"Bajpai A, Bharathi V, Patel BK. Therapeutic targeting of the oxidative stress generated by pathological molecular pathways in the neurodegenerative diseases, ALS and Huntington\u2019s. Eur J Pharmacol. 2025;987:177187. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177187.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"4820_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1474-4422(25)00109-7","volume":"24","author":"R Balendra","year":"2025","unstructured":"Balendra R, Sreedharan J, Hallegger M, Luisier R, Lashuel HA, Gregory JM, et al. Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathy. Lancet Neurol. 2025;24(5):456\u201370. https:\/\/doi.org\/10.1016\/S1474-4422(25)00109-7.","journal-title":"Lancet Neurol"},{"issue":"9","key":"4820_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41591-022-01956-3","volume":"28","author":"RH Baloh","year":"2022","unstructured":"Baloh RH, Johnson JP, Avalos P, Allred P, Svendsen S, Gowing G, et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial. Nat Med. 2022;28(9):1813\u201322. https:\/\/doi.org\/10.1038\/s41591-022-01956-3.","journal-title":"Nat Med"},{"issue":"6","key":"4820_CR11","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200116","volume":"10","author":"SA Banack","year":"2020","unstructured":"Banack SA, Dunlop RA, Cox PA. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis\/motor neuron disease. Open Biol. 2020;10(6):200116. https:\/\/doi.org\/10.1098\/rsob.200116.","journal-title":"Open Biol"},{"issue":"2","key":"4820_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/genes14020325","volume":"14","author":"M Barbo","year":"2023","unstructured":"Barbo M, Ravnik-Glavac M. Extracellular vesicles as potential biomarkers in amyotrophic lateral sclerosis. Genes (Basel). 2023;14(2):325. https:\/\/doi.org\/10.3390\/genes14020325.","journal-title":"Genes (Basel)"},{"issue":"22","key":"4820_CR13","doi-asserted-by":"publisher","first-page":"15699","DOI":"10.1074\/jbc.M112.425066","volume":"288","author":"M Basso","year":"2013","unstructured":"Basso M, Pozzi S, Tortarolo M, Fiordaliso F, Bisighini C, Pasetto L, et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem. 2013;288(22):15699\u2013711. https:\/\/doi.org\/10.1074\/jbc.M112.425066.","journal-title":"J Biol Chem"},{"issue":"1","key":"4820_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/27694127.2025.2474796","volume":"4","author":"J Beckers","year":"2025","unstructured":"Beckers J, Van Damme P. The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Autophagy Rep. 2025;4(1):2474796. https:\/\/doi.org\/10.1080\/27694127.2025.2474796.","journal-title":"Autophagy Rep"},{"issue":"24","key":"4820_CR15","doi-asserted-by":"publisher","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","volume":"93","author":"JD Berry","year":"2019","unstructured":"Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, et al. NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results. Neurology. 2019;93(24):e2294\u2013305. https:\/\/doi.org\/10.1212\/WNL.0000000000008620.","journal-title":"Neurology"},{"issue":"11","key":"4820_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40265-023-01904-6","volume":"83","author":"HA Blair","year":"2023","unstructured":"Blair HA. Tofersen: first approval. Drugs. 2023;83(11):1039\u201343. https:\/\/doi.org\/10.1007\/s40265-023-01904-6.","journal-title":"Drugs"},{"issue":"7","key":"4820_CR17","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.4049\/jimmunol.168.7.3235","volume":"168","author":"N Blanchard","year":"2002","unstructured":"Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo G, et al. TCR activation of human T cells induces the production of exosomes bearing the TCR\/CD3\/zeta complex. J Immunol. 2002;168(7):3235\u201341. https:\/\/doi.org\/10.4049\/jimmunol.168.7.3235.","journal-title":"J Immunol"},{"key":"4820_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091087","author":"R Bonafede","year":"2019","unstructured":"Bonafede R, Brandi J, Manfredi M, Scambi I, Schiaffino L, Merigo F, et al. The anti-apoptotic effect of ASC-exosomes in an in vitro ALS model and their proteomic analysis. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091087.","journal-title":"Cells"},{"key":"4820_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00080","volume":"11","author":"R Bonafede","year":"2017","unstructured":"Bonafede R, Mariotti R. ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles. Front Cell Neurosci. 2017;11:80. https:\/\/doi.org\/10.3389\/fncel.2017.00080.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"4820_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.yexcr.2015.12.009","volume":"340","author":"R Bonafede","year":"2016","unstructured":"Bonafede R, Scambi I, Peroni D, Potrich V, Boschi F, Benati D, et al. Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp Cell Res. 2016;340(1):150\u20138. https:\/\/doi.org\/10.1016\/j.yexcr.2015.12.009.","journal-title":"Exp Cell Res"},{"key":"4820_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103651","author":"R Bonafede","year":"2020","unstructured":"Bonafede R, Turano E, Scambi I, Busato A, Bontempi P, Virla F, et al. ASC-exosomes ameliorate the disease progression in SOD1(G93A) murine model underlining their potential therapeutic use in human ALS. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21103651.","journal-title":"Int J Mol Sci"},{"key":"4820_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115946","author":"MA Boylan","year":"2023","unstructured":"Boylan MA, Pincetic A, Romano G, Tatton N, Kenkare-Mitra S, Rosenthal A. Targeting progranulin as an immuno-neurology therapeutic approach. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242115946.","journal-title":"Int J Mol Sci"},{"key":"4820_CR23","unstructured":"Brainstorm-Cell Therapeutics. (2017 \u2013 2024, February 29). Safety and efficacy of repeated administrations of NurOwn\u00ae in ALS patients. Identifier NCT03280056. https:\/\/clinicaltrials.gov\/study\/NCT03280056"},{"key":"4820_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","volume":"33","author":"SW Brubaker","year":"2015","unstructured":"Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015;33:257\u201390. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112240.","journal-title":"Annu Rev Immunol"},{"key":"4820_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01070","volume":"13","author":"E Calabria","year":"2019","unstructured":"Calabria E, Scambi I, Bonafede R, Schiaffino L, Peroni D, Potrich V, et al. ASCs-exosomes recover coupling efficiency and mitochondrial membrane potential in an in vitro model of ALS. Front Neurosci. 2019;13:1070. https:\/\/doi.org\/10.3389\/fnins.2019.01070.","journal-title":"Front Neurosci"},{"issue":"6","key":"4820_CR26","doi-asserted-by":"publisher","first-page":"5999","DOI":"10.3390\/cimb46060358","volume":"46","author":"E Carata","year":"2024","unstructured":"Carata E, Muci M, Di Giulio S, Di Giulio T, Mariano S, Panzarini E. The neuromuscular disorder mediated by extracellular vesicles in amyotrophic lateral sclerosis. Curr Issues Mol Biol. 2024;46(6):5999\u20136017. https:\/\/doi.org\/10.3390\/cimb46060358.","journal-title":"Curr Issues Mol Biol"},{"key":"4820_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411251","author":"E Carata","year":"2023","unstructured":"Carata E, Muci M, Di Giulio S, Mariano S, Panzarini E. Looking to the future of the role of macrophages and extracellular vesicles in neuroinflammation in ALS. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241411251.","journal-title":"Int J Mol Sci"},{"key":"4820_CR28","unstructured":"Cellenkos, Inc. (2023 \u2013 2025, April 11). Regulatory T cells for amyotrophic lateral sclerosis (REGALS). Identifier NCT05695521. https:\/\/clinicaltrials.gov\/study\/NCT05695521"},{"key":"4820_CR29","unstructured":"Cerillo JL, Parmar M. (2026). Tofersen. In StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37603661"},{"key":"4820_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fnagi.2016.00246","volume":"8","author":"L Chen","year":"2016","unstructured":"Chen L, Liu X, Tang L, Zhang N, Fan D. Long-term use of riluzole could improve the prognosis of sporadic amyotrophic lateral sclerosis patients: a real-world cohort study in China. Front Aging Neurosci. 2016;8:246. https:\/\/doi.org\/10.3389\/fnagi.2016.00246.","journal-title":"Front Aging Neurosci"},{"key":"4820_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117070","volume":"418","author":"PC Chen","year":"2020","unstructured":"Chen PC, Wu D, Hu CJ, Chen HY, Hsieh YC, Huang CC. Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: a longitudinal follow-up study. J Neurol Sci. 2020;418:117070. https:\/\/doi.org\/10.1016\/j.jns.2020.117070.","journal-title":"J Neurol Sci"},{"key":"4820_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.718803","volume":"9","author":"QY Chen","year":"2021","unstructured":"Chen QY, Wen T, Wu P, Jia R, Zhang R, Dang J. Exosomal proteins and miRNAs as mediators of amyotrophic lateral sclerosis. Front Cell Dev Biol. 2021;9:718803. https:\/\/doi.org\/10.3389\/fcell.2021.718803.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"4820_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads5249","volume":"11","author":"Y Chen","year":"2025","unstructured":"Chen Y, Douanne N, Wu T, Kaur I, Tsering T, Erzingatzian A, et al. Leveraging nature\u2019s nanocarriers: translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications. Sci Adv. 2025;11(9):eads5249. https:\/\/doi.org\/10.1126\/sciadv.ads5249.","journal-title":"Sci Adv"},{"key":"4820_CR34","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fnins.2019.00574","volume":"13","author":"Y Chen","year":"2019","unstructured":"Chen Y, Xia K, Chen L, Fan D. Increased interleukin-6 levels in the astrocyte-derived exosomes of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2019;13:574. https:\/\/doi.org\/10.3389\/fnins.2019.00574.","journal-title":"Front Neurosci"},{"issue":"4","key":"4820_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06620-x","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xia X, Yao M, Yang Y, Ao X, Zhang Z, et al. The dual role of mesenchymal stem cells in apoptosis regulation. Cell Death Dis. 2024;15(4):250. https:\/\/doi.org\/10.1038\/s41419-024-06620-x.","journal-title":"Cell Death Dis"},{"key":"4820_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107986","volume":"167","author":"A Chi\u00f2","year":"2020","unstructured":"Chi\u00f2 A, Mazzini L, Mora G. Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology. 2020;167:107986. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107986.","journal-title":"Neuropharmacology"},{"issue":"2","key":"4820_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","volume":"21","author":"CC Chou","year":"2018","unstructured":"Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD. Nat Neurosci. 2018;21(2):228\u201339. https:\/\/doi.org\/10.1038\/s41593-017-0047-3.","journal-title":"Nat Neurosci"},{"issue":"10","key":"4820_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106389","volume":"40","author":"ME Cicardi","year":"2021","unstructured":"Cicardi ME, Marrone L, Azzouz M, Trotti D. Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. EMBO J. 2021;40(10):e106389. https:\/\/doi.org\/10.15252\/embj.2020106389.","journal-title":"EMBO J"},{"key":"4820_CR39","unstructured":"Corestemchemon, Inc. (2021 \u2013 2025, January 10). Evaluation the efficacy and safety of multiple Lenzumestrocel (Neuronata-R\u00ae Inj.) treatment in patients with ALS (ALSummit). Identifier NCT04745299. https:\/\/clinicaltrials.gov\/study\/NCT04745299"},{"issue":"3\u20134","key":"4820_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17582024.2024.2344396","volume":"14","author":"JJ Crose","year":"2024","unstructured":"Crose JJ, Crose A, Ransom JT, Lightner AL. Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for amyotrophic lateral sclerosis. Neurodegener Dis Manag. 2024;14(3\u20134):111\u20137. https:\/\/doi.org\/10.1080\/17582024.2024.2344396.","journal-title":"Neurodegener Dis Manag"},{"issue":"3","key":"4820_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/mus.27472","volume":"65","author":"ME Cudkowicz","year":"2022","unstructured":"Cudkowicz ME, Lindborg SR, Goyal NA, Miller RG, Burford MJ, Berry JD, et al. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. Muscle Nerve. 2022;65(3):291\u2013302. https:\/\/doi.org\/10.1002\/mus.27472.","journal-title":"Muscle Nerve"},{"key":"4820_CR42","doi-asserted-by":"publisher","first-page":"2616653","DOI":"10.1155\/sci\/2616653","volume":"2025","author":"C D'Arrigo","year":"2025","unstructured":"D\u2019Arrigo C, Labbate S, Galante D. Boosting the therapeutic potential of extracellular vesicles derived from mesenchymal stem cells via advanced preconditioning for neurodegenerative disorders. Stem Cells Int. 2025;2025:2616653. https:\/\/doi.org\/10.1155\/sci\/2616653.","journal-title":"Stem Cells Int"},{"key":"4820_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115707","author":"S Dabrowska","year":"2024","unstructured":"Dabrowska S, Turano E, Scambi I, Virla F, Nodari A, Pezzini F, et al. A cellular model of amyotrophic lateral sclerosis to study the therapeutic effects of extracellular vesicles from adipose mesenchymal stem cells on microglial activation. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25115707.","journal-title":"Int J Mol Sci"},{"key":"4820_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.653688","volume":"15","author":"R Dafinca","year":"2021","unstructured":"Dafinca R, Barbagallo P, Talbot K. The role of mitochondrial dysfunction and ER stress in TDP-43 and C9ORF72 ALS. Front Cell Neurosci. 2021;15:653688. https:\/\/doi.org\/10.3389\/fncel.2021.653688.","journal-title":"Front Cell Neurosci"},{"key":"4820_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060971","author":"H Du","year":"2023","unstructured":"Du H, Huo Z, Chen Y, Zhao Z, Meng F, Wang X, et al. Induced pluripotent stem cells and their applications in amyotrophic lateral sclerosis. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12060971.","journal-title":"Cells"},{"issue":"4","key":"4820_CR46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1083\/jcb.201504057","volume":"211","author":"MS Feiler","year":"2015","unstructured":"Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, et al. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211(4):897\u2013911. https:\/\/doi.org\/10.1083\/jcb.201504057.","journal-title":"J Cell Biol"},{"issue":"3","key":"4820_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.24113","volume":"75","author":"EL Feldman","year":"2014","unstructured":"Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, et al. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann Neurol. 2014;75(3):363\u201373. https:\/\/doi.org\/10.1002\/ana.24113.","journal-title":"Ann Neurol"},{"issue":"10360","key":"4820_CR48","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/s0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400(10360):1363\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(22)01272-7.","journal-title":"Lancet"},{"issue":"5-6","key":"4820_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","volume":"15","author":"E Feneberg","year":"2014","unstructured":"Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR, et al. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5\u20136):351\u20136. https:\/\/doi.org\/10.3109\/21678421.2014.905606.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"4820_CR50","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1021\/acs.jmedchem.2c01572","volume":"66","author":"IC Fontana","year":"2023","unstructured":"Fontana IC, Souza DG, Souza DO, Gee A, Zimmer ER, Bongarzone S. A medicinal chemistry perspective on excitatory amino acid transporter 2 dysfunction in neurodegenerative diseases. J Med Chem. 2023;66(4):2330\u201346. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01572.","journal-title":"J Med Chem"},{"key":"4820_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249593","author":"S Forostyak","year":"2020","unstructured":"Forostyak S, Forostyak O, Kwok JCF, Romanyuk N, Rehorova M, Kriska J, et al. Transplantation of neural precursors derived from induced pluripotent cells preserve perineuronal nets and stimulate neural plasticity in ALS rats. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21249593.","journal-title":"Int J Mol Sci"},{"key":"4820_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010035","author":"L Frawley","year":"2024","unstructured":"Frawley L, Taylor NT, Sivills O, McPhillamy E, To TD, Wu Y, et al. Stem cell therapy for the treatment of amyotrophic lateral sclerosis: comparison of the efficacy of mesenchymal stem cells, neural stem cells, and induced pluripotent stem cells. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines13010035.","journal-title":"Biomedicines"},{"key":"4820_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jconrel.2014.11.029","volume":"205","author":"G Fuhrmann","year":"2015","unstructured":"Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release. 2015;205:35\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.029.","journal-title":"J Control Release"},{"issue":"6","key":"4820_CR54","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/stem.1083","volume":"30","author":"Y Fujimoto","year":"2012","unstructured":"Fujimoto Y, Abematsu M, Falk A, Tsujimura K, Sanosaka T, Juliandi B, et al. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells. 2012;30(6):1163\u201373. https:\/\/doi.org\/10.1002\/stem.1083.","journal-title":"Stem Cells"},{"issue":"1","key":"4820_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.14336\/AD.2024.1629","volume":"17","author":"R Gao","year":"2025","unstructured":"Gao R, Gao Y, Su W, Wang R. Decoding microglial polarization and metabolic reprogramming in neurodegenerative diseases: implications for disease progression and therapy. Aging Dis. 2025;17(1):91\u2013113. https:\/\/doi.org\/10.14336\/AD.2024.1629.","journal-title":"Aging Dis"},{"issue":"4","key":"4820_CR56","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4103\/1673-5374.294337","volume":"16","author":"S Garbuzova-Davis","year":"2021","unstructured":"Garbuzova-Davis S, Borlongan CV. Stem cell-derived extracellular vesicles as potential mechanism for repair of microvascular damage within and outside of the central nervous system in amyotrophic lateral sclerosis: perspective schema. Neural Regen Res. 2021;16(4):680\u20131. https:\/\/doi.org\/10.4103\/1673-5374.294337.","journal-title":"Neural Regen Res"},{"key":"4820_CR57","doi-asserted-by":"publisher","first-page":"2785343","DOI":"10.1155\/2020\/2785343","volume":"2020","author":"M Gatti","year":"2020","unstructured":"Gatti M, Zavatti M, Beretti F, Giuliani D, Vandini E, Ottani A, et al. Oxidative stress in Alzheimer\u2019s disease: in vitro therapeutic effect of amniotic fluid stem cells extracellular vesicles. Oxid Med Cell Longev. 2020;2020:2785343. https:\/\/doi.org\/10.1155\/2020\/2785343.","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"4820_CR58","doi-asserted-by":"publisher","first-page":"C1085","DOI":"10.1152\/ajpcell.00238.2025","volume":"329","author":"LT Ghaffari","year":"2025","unstructured":"Ghaffari LT, Welebob EA, Newton SEB, Boehringer AV, Cyliax KL, Pasinelli P, et al. Neuronal activity-dependent gene dysregulation in C9orf72 i(3)Neuronal models of ALS\/FTD pathogenesis. Am J Physiol Cell Physiol. 2025;329(4):C1085\u2013100. https:\/\/doi.org\/10.1152\/ajpcell.00238.2025.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"4820_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2021.12.008","volume":"29","author":"E Giacomelli","year":"2022","unstructured":"Giacomelli E, Vahsen BF, Calder EL, Xu Y, Scaber J, Gray E, et al. Human stem cell models of neurodegeneration: from basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell. 2022;29(1):11\u201335. https:\/\/doi.org\/10.1016\/j.stem.2021.12.008.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4820_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81039-4","volume":"11","author":"D Giunti","year":"2021","unstructured":"Giunti D, Marini C, Parodi B, Usai C, Milanese M, Bonanno G, et al. Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation. Sci Rep. 2021;11(1):1740. https:\/\/doi.org\/10.1038\/s41598-021-81039-4.","journal-title":"Sci Rep"},{"issue":"6","key":"4820_CR61","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/acn3.567","volume":"5","author":"SA Goutman","year":"2018","unstructured":"Goutman SA, Brown MB, Glass JD, Boulis NM, Johe K, Hazel T, et al. Long-term phase 1\/2 intraspinal stem cell transplantation outcomes in ALS. Ann Clin Transl Neurol. 2018;5(6):730\u201340. https:\/\/doi.org\/10.1002\/acn3.567.","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"4820_CR62","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/s1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):480\u201393. https:\/\/doi.org\/10.1016\/s1474-4422(21)00465-8.","journal-title":"Lancet Neurol"},{"issue":"10","key":"4820_CR63","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41582-023-00867-2","volume":"19","author":"SA Goutman","year":"2023","unstructured":"Goutman SA, Savelieff MG, Jang DG, Hur J, Feldman EL. The amyotrophic lateral sclerosis exposome: recent advances and future directions. Nat Rev Neurol. 2023;19(10):617\u201334. https:\/\/doi.org\/10.1038\/s41582-023-00867-2.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"4820_CR64","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1073\/pnas.1312245111","volume":"111","author":"LI Grad","year":"2014","unstructured":"Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O\u2019Neill MA, et al. Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci USA. 2014;111(9):3620\u20135. https:\/\/doi.org\/10.1073\/pnas.1312245111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4820_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2023.137493","volume":"816","author":"T Gschwendtberger","year":"2023","unstructured":"Gschwendtberger T, Thau-Habermann N, von der Ohe J, Luo T, Hass R, Petri S. Protective effects of EVs\/exosomes derived from permanently growing human MSC on primary murine ALS motor neurons. Neurosci Lett. 2023;816:137493. https:\/\/doi.org\/10.1016\/j.neulet.2023.137493.","journal-title":"Neurosci Lett"},{"issue":"1","key":"4820_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ctn6010005","volume":"6","author":"ZI Gunes","year":"2022","unstructured":"Gunes ZI, Kan VWY, Jiang S, Logunov E, Ye X, Liebscher S. Cortical hyperexcitability in the driver\u2019s seat in ALS. Clin Transl Neurosci. 2022;6(1):5. https:\/\/doi.org\/10.3390\/ctn6010005.","journal-title":"Clin Transl Neurosci"},{"key":"4820_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081959","author":"MD Hade","year":"2021","unstructured":"Hade MD, Suire CN, Suo Z. Mesenchymal stem cell-derived exosomes: applications in regenerative medicine. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10081959.","journal-title":"Cells"},{"key":"4820_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2025.102809","volume":"252","author":"M Haidar","year":"2025","unstructured":"Haidar M, Viden A, Daniel C, Cuic B, Wang T, Rosier M, et al. Cortical hyperexcitability drives dying forward amyotrophic lateral sclerosis symptoms and pathology in mice. Prog Neurobiol. 2025;252:102809. https:\/\/doi.org\/10.1016\/j.pneurobio.2025.102809.","journal-title":"Prog Neurobiol"},{"key":"4820_CR69","doi-asserted-by":"publisher","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17085. https:\/\/doi.org\/10.1038\/nrdp.2017.85.","journal-title":"Nat Rev Dis Primers"},{"key":"4820_CR70","doi-asserted-by":"publisher","unstructured":"Hartmann A, Muth C, Dabrowski O, Krasemann S, Glatzel M. Exosomes and the Prion Protein: More than One Truth. Front Neurosci. 2017;11:194. https:\/\/doi.org\/10.3389\/fnins.2017.00194","DOI":"10.3389\/fnins.2017.00194"},{"key":"4820_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091990","author":"A Hopf","year":"2020","unstructured":"Hopf A, Schaefer DJ, Kalbermatten DF, Guzman R, Madduri S. Schwann cell-like cells: origin and usability for repair and regeneration of the peripheral and central nervous system. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9091990.","journal-title":"Cells"},{"key":"4820_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133148","author":"T Hosaka","year":"2019","unstructured":"Hosaka T, Yamashita T, Tamaoka A, Kwak S. Extracellular RNAs as biomarkers of sporadic amyotrophic lateral sclerosis and other neurodegenerative diseases. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133148.","journal-title":"Int J Mol Sci"},{"key":"4820_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010281","author":"YH Hsueh","year":"2024","unstructured":"Hsueh YH, Chen KP, Buddhakosai W, Le PN, Hsiung YW, Tu YY, et al. Secretome of the olfactory ensheathing cells influences the behavior of neural stem cells. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms26010281.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4820_CR74","doi-asserted-by":"publisher","first-page":"e70299","DOI":"10.1002\/mco2.70299","volume":"6","author":"M Huang","year":"2025","unstructured":"Huang M, Long A, Hao L, Shi Z, Zhang M. Astrocyte in neurological disease: pathogenesis and therapy. MedComm. 2025;6(8):e70299. https:\/\/doi.org\/10.1002\/mco2.70299.","journal-title":"MedComm"},{"issue":"3","key":"4820_CR75","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.14336\/AD.2023.0807","volume":"15","author":"Q Huang","year":"2024","unstructured":"Huang Q, Wang Y, Chen S, Liang F. Glycometabolic reprogramming of microglia in neurodegenerative diseases: insights from neuroinflammation. Aging Dis. 2024;15(3):1155\u201375. https:\/\/doi.org\/10.14336\/AD.2023.0807.","journal-title":"Aging Dis"},{"issue":"5","key":"4820_CR76","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/1061186X.2016.1223676","volume":"25","author":"R Huey","year":"2017","unstructured":"Huey R, Hawthorne S, McCarron P. The potential use of rabies virus glycoprotein-derived peptides to facilitate drug delivery into the central nervous system: a mini review. J Drug Target. 2017;25(5):379\u201385. https:\/\/doi.org\/10.1080\/1061186X.2016.1223676.","journal-title":"J Drug Target"},{"issue":"15 Suppl","key":"4820_CR77","first-page":"S320","volume":"24","author":"D Hulisz","year":"2018","unstructured":"Hulisz D. Amyotrophic lateral sclerosis: disease state overview. Am J Manag Care. 2018;24(15 Suppl):S320-s326.","journal-title":"Am J Manag Care"},{"issue":"1","key":"4820_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-025-00484-7","volume":"14","author":"M Izco","year":"2025","unstructured":"Izco M, Sola C, Schleef M, Schmeer M, de Toro M, Verona G, et al. Development of human targeted extracellular vesicles loaded with shRNA minicircles to prevent parkinsonian pathology. Transl Neurodegener. 2025;14(1):26. https:\/\/doi.org\/10.1186\/s40035-025-00484-7.","journal-title":"Transl Neurodegener"},{"issue":"2","key":"4820_CR79","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/med.21528","volume":"39","author":"MK Jaiswal","year":"2019","unstructured":"Jaiswal MK. Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med Res Rev. 2019;39(2):733\u201348. https:\/\/doi.org\/10.1002\/med.21528.","journal-title":"Med Res Rev"},{"issue":"Pt B","key":"4820_CR80","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.phrs.2016.02.002","volume":"113","author":"A Jarmalavi\u010di\u016bt\u0117","year":"2016","unstructured":"Jarmalavi\u010di\u016bt\u0117 A, Pivori\u016bnas A. Exosomes as a potential novel therapeutic tools against neurodegenerative diseases. Pharmacol Res. 2016;113(Pt B):816\u201322. https:\/\/doi.org\/10.1016\/j.phrs.2016.02.002.","journal-title":"Pharmacol Res"},{"issue":"13","key":"4820_CR81","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s40265-022-01769-1","volume":"82","author":"SA Johnson","year":"2022","unstructured":"Johnson SA, Fang T, De Marchi F, Neel D, Van Weehaeghe D, Berry JD, et al. Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents. Drugs. 2022;82(13):1367\u201388. https:\/\/doi.org\/10.1007\/s40265-022-01769-1.","journal-title":"Drugs"},{"issue":"12","key":"4820_CR82","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1038\/s41593-025-02096-w","volume":"28","author":"BJ Joseph","year":"2025","unstructured":"Joseph BJ, Marshall KA, Harley P, Mann JR, Alessandrini F, Vanoye CG, et al. TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS\/FTD. Nat Neurosci. 2025;28(12):2476\u201392. https:\/\/doi.org\/10.1038\/s41593-025-02096-w.","journal-title":"Nat Neurosci"},{"issue":"7","key":"4820_CR83","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/jnnp-2011-301826","volume":"83","author":"T Kanouchi","year":"2012","unstructured":"Kanouchi T, Ohkubo T, Yokota T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J Neurol Neurosurg Psychiatry. 2012;83(7):739\u201345. https:\/\/doi.org\/10.1136\/jnnp-2011-301826.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4820_CR84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2013.02.019","volume":"335","author":"M Katakowski","year":"2013","unstructured":"Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, et al. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 2013;335(1):201\u20134. https:\/\/doi.org\/10.1016\/j.canlet.2013.02.019.","journal-title":"Cancer Lett"},{"issue":"1","key":"4820_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63. https:\/\/doi.org\/10.1186\/s13287-018-0791-7.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"4820_CR86","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3390\/cimb44110351","volume":"44","author":"IV Kholodenko","year":"2022","unstructured":"Kholodenko IV, Kholodenko RV, Majouga AG, Yarygin KN. Apoptotic MSCs and MSC-derived apoptotic bodies as new therapeutic tools. Curr Issues Mol Biol. 2022;44(11):5153\u201372. https:\/\/doi.org\/10.3390\/cimb44110351.","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"4820_CR87","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s13311-022-01232-9","volume":"19","author":"G Kim","year":"2022","unstructured":"Kim G, Chen X, Yang Y. Pathogenic extracellular vesicle (EV) signaling in amyotrophic lateral sclerosis (ALS). Neurotherapeutics. 2022;19(4):1119\u201332. https:\/\/doi.org\/10.1007\/s13311-022-01232-9.","journal-title":"Neurotherapeutics"},{"issue":"5","key":"4820_CR88","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","volume":"108","author":"G Kim","year":"2020","unstructured":"Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108(5):822\u201342. https:\/\/doi.org\/10.1016\/j.neuron.2020.08.022.","journal-title":"Neuron"},{"issue":"3","key":"4820_CR89","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neulet.2009.10.074","volume":"468","author":"H Kim","year":"2010","unstructured":"Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC, et al. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett. 2010;468(3):190\u20134. https:\/\/doi.org\/10.1016\/j.neulet.2009.10.074.","journal-title":"Neurosci Lett"},{"key":"4820_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13121462","author":"S Kim","year":"2024","unstructured":"Kim S, Jung UJ, Kim SR. Role of oxidative stress in blood-brain barrier disruption and neurodegenerative diseases. Antioxidants (Basel). 2024. https:\/\/doi.org\/10.3390\/antiox13121462.","journal-title":"Antioxidants (Basel)"},{"key":"4820_CR91","doi-asserted-by":"publisher","unstructured":"Kim KS, Lee HJ, An J, Kim YB, Ra JC, Lim I, Kim SU (2014) Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model. Cell Transplant 2014;23(12):1585\u201397. https:\/\/doi.org\/10.3727\/096368913X673450","DOI":"10.3727\/096368913X673450"},{"issue":"2","key":"4820_CR92","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2025.01.003","volume":"32","author":"A Kirkeby","year":"2025","unstructured":"Kirkeby A, Main H, Carpenter M. Pluripotent stem-cell-derived therapies in clinical trial: a 2025 update. Cell Stem Cell. 2025;32(2):329\u201331. https:\/\/doi.org\/10.1016\/j.stem.2025.01.003.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4820_CR93","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.stem.2014.03.004","volume":"14","author":"E Kiskinis","year":"2014","unstructured":"Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14(6):781\u201395. https:\/\/doi.org\/10.1016\/j.stem.2014.03.004.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4820_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036857","volume":"7","author":"S Knippenberg","year":"2012","unstructured":"Knippenberg S, Thau N, Dengler R, Brinker T, Petri S. Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS. PLoS ONE. 2012;7(6):e36857. https:\/\/doi.org\/10.1371\/journal.pone.0036857.","journal-title":"PLoS ONE"},{"issue":"2","key":"4820_CR95","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","volume":"3","author":"T Kondo","year":"2014","unstructured":"Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, et al. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Reports. 2014;3(2):242\u20139. https:\/\/doi.org\/10.1016\/j.stemcr.2014.05.017.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"4820_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01570-6","volume":"15","author":"D Krishnan","year":"2025","unstructured":"Krishnan D, Talbot DL, Ashhurst JF, Park SB, Vucic S, Timmins HC, et al. Longitudinal assessment of cortical motor function in amyotrophic lateral sclerosis. Sci Rep. 2025;15(1):16978. https:\/\/doi.org\/10.1038\/s41598-025-01570-6.","journal-title":"Sci Rep"},{"issue":"2","key":"4820_CR97","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/jcsm.12945","volume":"13","author":"L Le Gall","year":"2022","unstructured":"Le Gall L, Duddy WJ, Martinat C, Mariot V, Connolly O, Milla V, et al. Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles. J Cachexia Sarcopenia Muscle. 2022;13(2):1385\u2013402. https:\/\/doi.org\/10.1002\/jcsm.12945.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"4820_CR98","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbrc.2016.09.069","volume":"479","author":"M Lee","year":"2016","unstructured":"Lee M, Ban JJ, Kim KY, Jeon GS, Im W, Sung JJ, et al. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro. Biochem Biophys Res Commun. 2016;479(3):434\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.069.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4820_CR99","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/thno.52570","volume":"11","author":"Y Liang","year":"2021","unstructured":"Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183\u201395. https:\/\/doi.org\/10.7150\/thno.52570.","journal-title":"Theranostics"},{"key":"4820_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176346","volume":"966","author":"JX Liao","year":"2024","unstructured":"Liao JX, Zhu FQ, Liu YY, Liu SC, Liu ZX, Zhang WJ. The role of olfactory ensheathing cells in the repair of nerve injury. Eur J Pharmacol. 2024;966:176346. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176346.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4820_CR101","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/nep3.26","volume":"1","author":"G Lockard","year":"2023","unstructured":"Lockard G, Gordon J, Schimmel S, Sayed BE, Monsour M, Garbuzova-Davis S, et al. Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: an updated review. Neuroprotection. 2023;1(2):130\u20138. https:\/\/doi.org\/10.1002\/nep3.26.","journal-title":"Neuroprotection"},{"issue":"11","key":"4820_CR102","doi-asserted-by":"publisher","DOI":"10.1096\/fba.2025-00126","volume":"7","author":"Y Luo","year":"2025","unstructured":"Luo Y, Xu Z, Li Z. Advances in induced pluripotent stem cell reprogramming and its application in amyotrophic lateral sclerosis: a review. FASEB Bioadv. 2025;7(11):e70065. https:\/\/doi.org\/10.1096\/fba.2025-00126.","journal-title":"FASEB Bioadv"},{"key":"4820_CR103","doi-asserted-by":"publisher","unstructured":"Luo Q, Xian P, Wang T, Wu S, Sun T, Wang W, Wang B, Yang H, Yang Y, Wang H, Liu W, Long Q. Antioxidant activity of mesenchymal stem cell-derived extracellular vesicles restores hippocampal neurons following seizure damage. Theranostics. 2021;11(12):5986-6005. https:\/\/doi.org\/10.7150\/thno.58632","DOI":"10.7150\/thno.58632"},{"issue":"5","key":"4820_CR104","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61(5):427\u201334. https:\/\/doi.org\/10.1002\/ana.21147.","journal-title":"Ann Neurol"},{"issue":"3","key":"4820_CR105","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/glia.24622","volume":"73","author":"S Majewski","year":"2025","unstructured":"Majewski S, Klein P, Boillee S, Clarke BE, Patani R. Towards an integrated approach for understanding glia in amyotrophic lateral sclerosis. Glia. 2025;73(3):591\u2013607. https:\/\/doi.org\/10.1002\/glia.24622.","journal-title":"Glia"},{"key":"4820_CR106","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuroscience.2013.05.034","volume":"248","author":"S Marconi","year":"2013","unstructured":"Marconi S, Bonaconsa M, Scambi I, Squintani GM, Rui W, Turano E, et al. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience. 2013;248:333\u201343. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.05.034.","journal-title":"Neuroscience"},{"issue":"10","key":"4820_CR107","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918\u201329. https:\/\/doi.org\/10.1111\/ene.14393.","journal-title":"Eur J Neurol"},{"issue":"8","key":"4820_CR108","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14712598.2018.1503248","volume":"18","author":"L Mazzini","year":"2018","unstructured":"Mazzini L, Ferrari D, Andjus PR, Buzanska L, Cantello R, De Marchi F, et al. Advances in stem cell therapy for amyotrophic lateral sclerosis. Expert Opin Biol Ther. 2018;18(8):865\u201381. https:\/\/doi.org\/10.1080\/14712598.2018.1503248.","journal-title":"Expert Opin Biol Ther"},{"key":"4820_CR109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","volume":"13","author":"L Mazzini","year":"2015","unstructured":"Mazzini L, Gelati M, Profico DC, Sgaravizzi G, ProjettiPensi M, Muzi G, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;13:17. https:\/\/doi.org\/10.1186\/s12967-014-0371-2.","journal-title":"J Transl Med"},{"issue":"2","key":"4820_CR110","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1517\/14712598.2016.1116516","volume":"16","author":"L Mazzini","year":"2016","unstructured":"Mazzini L, Vescovi A, Cantello R, Gelati M, Vercelli A. Stem cells therapy for ALS. Expert Opin Biol Ther. 2016;16(2):187\u201399. https:\/\/doi.org\/10.1517\/14712598.2016.1116516.","journal-title":"Expert Opin Biol Ther"},{"key":"4820_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00262","volume":"12","author":"L McAlary","year":"2019","unstructured":"McAlary L, Plotkin SS, Yerbury JJ, Cashman NR. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:262. https:\/\/doi.org\/10.3389\/fnmol.2019.00262.","journal-title":"Front Mol Neurosci"},{"key":"4820_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/life13010121","author":"G McCluskey","year":"2022","unstructured":"McCluskey G, Morrison KE, Donaghy C, Rene F, Duddy W, Duguez S. Extracellular vesicles in amyotrophic lateral sclerosis. Life (Basel). 2022. https:\/\/doi.org\/10.3390\/life13010121.","journal-title":"Life (Basel)"},{"issue":"23","key":"4820_CR113","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1016\/j.cell.2025.07.045","volume":"188","author":"ZT McEachin","year":"2025","unstructured":"McEachin ZT, Chung M, Stratton SA, Han C, Kim WJ, Sheth U, et al. Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS. Cell. 2025;188(23):6424\u201335. https:\/\/doi.org\/10.1016\/j.cell.2025.07.045.","journal-title":"Cell"},{"issue":"1\u20132","key":"4820_CR114","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/21678421.2024.2401131","volume":"26","author":"T Meyer","year":"2025","unstructured":"Meyer T, Schumann P, Grehl T, Weyen U, Petri S, Rodiger A, et al. SOD1 gene screening in ALS - frequency of mutations, patients\u2019 attitudes to genetic information and transition to tofersen treatment in a multi-center program. Amyotroph Lateral Scler Frontotemporal Degener. 2025;26(1\u20132):162\u201371. https:\/\/doi.org\/10.1080\/21678421.2024.2401131.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"4820_CR115","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jamaneurol.2025.4946","volume":"83","author":"TM Miller","year":"2026","unstructured":"Miller TM, Cudkowicz ME, Shaw PJ, Genge A, Sobue G, Bucelli RC, et al. Long-term tofersen in SOD1 amyotrophic lateral sclerosis. JAMA Neurol. 2026;83(2):115\u201325. https:\/\/doi.org\/10.1001\/jamaneurol.2025.4946.","journal-title":"JAMA Neurol"},{"issue":"3","key":"4820_CR116","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1474-4422(25)00026-2","volume":"24","author":"S Mizielinska","year":"2025","unstructured":"Mizielinska S, Hautbergue GM, Gendron TF, van Blitterswijk M, Hardiman O, Ravits J, et al. Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics. Lancet Neurol. 2025;24(3):261\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(25)00026-2.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4820_CR117","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S1474-4422(24)00517-9","volume":"24","author":"TG Moens","year":"2025","unstructured":"Moens TG, Da Cruz S, Neumann M, Shelkovnikova TA, Shneider NA, Van Den Bosch L. Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implications. Lancet Neurol. 2025;24(2):166\u201378. https:\/\/doi.org\/10.1016\/S1474-4422(24)00517-9.","journal-title":"Lancet Neurol"},{"key":"4820_CR118","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bioactmat.2024.02.021","volume":"36","author":"S Moghassemi","year":"2024","unstructured":"Moghassemi S, Dadashzadeh A, Sousa MJ, Vlieghe H, Yang J, Le\u00f3n-F\u00e9lix CM, et al. Extracellular vesicles in nanomedicine and regenerative medicine: a review over the last decade. Bioact Mater. 2024;36:126\u201356. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.02.021.","journal-title":"Bioact Mater"},{"key":"4820_CR119","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/5584_2017_71","volume":"1083","author":"I Mortada","year":"2018","unstructured":"Mortada I, Mortada R, Al Bazzal M. Dental pulp stem cells and neurogenesis. Adv Exp Med Biol. 2018;1083:63\u201375. https:\/\/doi.org\/10.1007\/5584_2017_71.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"4820_CR120","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMoa2005056","volume":"383","author":"C Mueller","year":"2020","unstructured":"Mueller C, Berry JD, McKenna-Yasek DM, Gernoux G, Owegi MA, Pothier LM, et al. SOD1 suppression with adeno-associated virus and microRNA in familial ALS. N Engl J Med. 2020;383(2):151\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2005056.","journal-title":"N Engl J Med"},{"issue":"1","key":"4820_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06327-4","volume":"23","author":"JY Nam","year":"2022","unstructured":"Nam JY, Lee TY, Kim K, Chun S, Kim MS, Shin JH, et al. Efficacy and safety of Lenzumestrocel (Neuronata-R(R) inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial. Trials. 2022;23(1):415. https:\/\/doi.org\/10.1186\/s13063-022-06327-4.","journal-title":"Trials"},{"key":"4820_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/cells13242137","author":"YH Nam","year":"2024","unstructured":"Nam YH, Kim JS, Yum Y, Yoon J, Song H, Kim HJ, et al. Application of mesenchymal stem cell-derived schwann cell-like cells spared neuromuscular junctions and enhanced functional recovery after peripheral nerve injury. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13242137.","journal-title":"Cells"},{"issue":"2","key":"4820_CR123","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/hmg\/ddt425","volume":"23","author":"M Nizzardo","year":"2014","unstructured":"Nizzardo M, Simone C, Rizzo F, Ruggieri M, Salani S, Riboldi G, et al. Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum Mol Genet. 2014;23(2):342\u201354. https:\/\/doi.org\/10.1093\/hmg\/ddt425.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4820_CR124","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13024-025-00867-4","volume":"20","author":"MY Noh","year":"2025","unstructured":"Noh MY, Kwon HS, Kwon MS, Nahm M, Jin HK, Bae JS, et al. Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions. Mol Neurodegener. 2025;20(1):82. https:\/\/doi.org\/10.1186\/s13024-025-00867-4.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4820_CR125","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-025-00848-7","volume":"20","author":"MY Noh","year":"2025","unstructured":"Noh MY, Oh SI, Kim YE, Cha SJ, Sung W, Oh KW, et al. Mutations in NEK1 cause ciliary dysfunction as a novel pathogenic mechanism in amyotrophic lateral sclerosis. Mol Neurodegener. 2025;20(1):59. https:\/\/doi.org\/10.1186\/s13024-025-00848-7.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4820_CR126","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4(1):124\u201334. https:\/\/doi.org\/10.1016\/j.celrep.2013.06.007.","journal-title":"Cell Rep"},{"key":"4820_CR127","unstructured":"Novabio Therapeutics. (2024 \u2013 2025, September 25). Clinical study of regulatory T cells (Tregs) in the treatment of neurodegenerative diseases. Identifier NCT06671236. https:\/\/clinicaltrials.gov\/study\/NCT06671236"},{"issue":"5","key":"4820_CR128","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/jnc.16005","volume":"167","author":"H Okano","year":"2023","unstructured":"Okano H, Morimoto S, Kato C, Nakahara J, Takahashi S. Induced pluripotent stem cells-based disease modeling, drug screening, clinical trials, and reverse translational research for amyotrophic lateral sclerosis. J Neurochem. 2023;167(5):603\u201314. https:\/\/doi.org\/10.1111\/jnc.16005.","journal-title":"J Neurochem"},{"issue":"10","key":"4820_CR129","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1916945","volume":"383","author":"S Paganoni","year":"2020","unstructured":"Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, et al. Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis. N Engl J Med. 2020;383(10):919\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1916945.","journal-title":"N Engl J Med"},{"issue":"1","key":"4820_CR130","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13287-020-01761-0","volume":"11","author":"Q Pan","year":"2020","unstructured":"Pan Q, Kuang X, Cai S, Wang X, Du D, Wang J, et al. MiR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury. Stem Cell Res Ther. 2020;11(1):260. https:\/\/doi.org\/10.1186\/s13287-020-01761-0.","journal-title":"Stem Cell Res Ther"},{"key":"4820_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1184435","volume":"15","author":"R Pan","year":"2023","unstructured":"Pan R, Chen D, Hou L, Hu R, Jiao Z. Small extracellular vesicles: a novel drug delivery system for neurodegenerative disorders. Front Aging Neurosci. 2023;15:1184435. https:\/\/doi.org\/10.3389\/fnagi.2023.1184435.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"4820_CR132","doi-asserted-by":"publisher","first-page":"dmm.031625","DOI":"10.1242\/dmm.031625","volume":"11","author":"O Pansarasa","year":"2018","unstructured":"Pansarasa O, Bordoni M, Drufuca L, Diamanti L, Sproviero D, Trotti R, et al. Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms. Dis Model Mech. 2018;11(3):dmm.031625. https:\/\/doi.org\/10.1242\/dmm.031625.","journal-title":"Dis Model Mech"},{"key":"4820_CR133","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","volume":"192","author":"L Pascucci","year":"2014","unstructured":"Pascucci L, Cocc\u00e8 V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014;192:262\u201370. https:\/\/doi.org\/10.1016\/j.jconrel.2014.07.042.","journal-title":"J Control Release"},{"issue":"1","key":"4820_CR134","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-021-00470-3","volume":"16","author":"L Pasetto","year":"2021","unstructured":"Pasetto L, Callegaro S, Corbelli A, Fiordaliso F, Ferrara D, Brunelli L, et al. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis. Mol Neurodegener. 2021;16(1):52. https:\/\/doi.org\/10.1186\/s13024-021-00470-3.","journal-title":"Mol Neurodegener"},{"issue":"10","key":"4820_CR135","doi-asserted-by":"publisher","first-page":"272","DOI":"10.22270\/jddt.v15i10.7424","volume":"15","author":"N Patel","year":"2025","unstructured":"Patel N, Satapathy T, Sahu P, Satapathy A, Bhardwaj SK, Satapathy A, et al. Molecular mechanisms of mitochondrial dysfunction in neurodegenerative diseases: pharmacological targets and therapeutic advances. J Drug Deliv Ther. 2025;15(10):272\u201394. https:\/\/doi.org\/10.22270\/jddt.v15i10.7424.","journal-title":"J Drug Deliv Ther"},{"issue":"7","key":"4820_CR136","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1093\/brain\/awae049","volume":"147","author":"N Pavey","year":"2024","unstructured":"Pavey N, Hannaford A, van den Bos M, Kiernan MC, Menon P, Vucic S. Distinct neuronal circuits mediate cortical hyperexcitability in amyotrophic lateral sclerosis. Brain. 2024;147(7):2344\u201356. https:\/\/doi.org\/10.1093\/brain\/awae049.","journal-title":"Brain"},{"issue":"33","key":"4820_CR137","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.2174\/1381612823666170622095802","volume":"23","author":"M Pehar","year":"2017","unstructured":"Pehar M, Harlan BA, Killoy KM, Vargas MR. Role and therapeutic potential of astrocytes in amyotrophic lateral sclerosis. Curr Pharm Des. 2017;23(33):5010\u201321. https:\/\/doi.org\/10.2174\/1381612823666170622095802.","journal-title":"Curr Pharm Des"},{"key":"4820_CR138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnins.2017.00273","volume":"11","author":"S Pinto","year":"2017","unstructured":"Pinto S, Cunha C, Barbosa M, Vaz AR, Brites D. Exosomes from NSC-34 cells transfected with hSOD1-G93A are enriched in miR-124 and drive alterations in microglia phenotype. Front Neurosci. 2017;11:273. https:\/\/doi.org\/10.3389\/fnins.2017.00273.","journal-title":"Front Neurosci"},{"issue":"1","key":"4820_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04374-7","volume":"16","author":"PHL Putri","year":"2025","unstructured":"Putri PHL, Alamudi SH, Dong X, Fu Y. Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker. Stem Cell Res Ther. 2025;16(1):263. https:\/\/doi.org\/10.1186\/s13287-025-04374-7.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"4820_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70199","volume":"14","author":"Z Qiao","year":"2025","unstructured":"Qiao Z, Choi S, Chen Z, Rodriguez RM, Wang Q, Yang Z, et al. Targeted intracellular delivery via precision programming of ARRDC1-mediated microvesicles. J Extracell Vesicles. 2025;14(12):e70199. https:\/\/doi.org\/10.1002\/jev2.70199.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"4820_CR141","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bcmd.2005.05.002","volume":"35","author":"BJ Quah","year":"2005","unstructured":"Quah BJ, O\u2019Neill HC. The immunogenicity of dendritic cell-derived exosomes. Blood Cells Mol Dis. 2005;35(2):94\u2013110. https:\/\/doi.org\/10.1016\/j.bcmd.2005.05.002.","journal-title":"Blood Cells Mol Dis"},{"key":"4820_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169299","author":"R Raghunathan","year":"2022","unstructured":"Raghunathan R, Turajane K, Wong LC. Biomarkers in neurodegenerative diseases: proteomics spotlight on ALS and Parkinson\u2019s disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23169299.","journal-title":"Int J Mol Sci"},{"key":"4820_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1507498","volume":"11","author":"D Raineri","year":"2024","unstructured":"Raineri D, De Marchi F, Vilardo B, Barbero Mazzucca C, Scotti L, Kustrimovic N, et al. Circulating GLAST(+) EVs are increased in amyotrophic lateral sclerosis. Front Mol Biosci. 2024;11:1507498. https:\/\/doi.org\/10.3389\/fmolb.2024.1507498.","journal-title":"Front Mol Biosci"},{"key":"4820_CR144","unstructured":"Rapa Therapeutics LLC. (2025, January 2 \u2013 2027, June 1). RAPA-501 therapy for ALS. Identifier NCT04220190. https:\/\/clinicaltrials.gov\/study\/NCT04220190"},{"issue":"4","key":"4820_CR145","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373\u201383. https:\/\/doi.org\/10.1083\/jcb.201211138.","journal-title":"J Cell Biol"},{"key":"4820_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123019","volume":"356","author":"B Saikia","year":"2024","unstructured":"Saikia B, Dhanushkodi A. Engineered exosome therapeutics for neurodegenerative diseases. Life Sci. 2024;356:123019. https:\/\/doi.org\/10.1016\/j.lfs.2024.123019.","journal-title":"Life Sci"},{"issue":"1","key":"4820_CR147","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1172\/jci59251","volume":"122","author":"K Sakai","year":"2012","unstructured":"Sakai K, Yamamoto A, Matsubara K, Nakamura S, Naruse M, Yamagata M, et al. Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest. 2012;122(1):80\u201390. https:\/\/doi.org\/10.1172\/jci59251.","journal-title":"J Clin Invest"},{"issue":"738","key":"4820_CR148","doi-asserted-by":"publisher","first-page":"eadg3665","DOI":"10.1126\/scitranslmed.adg3665","volume":"16","author":"J Scekic-Zahirovic","year":"2024","unstructured":"Scekic-Zahirovic J, Benetton C, Brunet A, Ye X, Logunov E, Douchamps V, et al. Cortical hyperexcitability in mouse models and patients with amyotrophic lateral sclerosis is linked to noradrenaline deficiency. Sci Transl Med. 2024;16(738):eadg3665. https:\/\/doi.org\/10.1126\/scitranslmed.adg3665.","journal-title":"Sci Transl Med"},{"key":"4820_CR149","unstructured":"Shanghai East Hospital. (2025 \u2013 2025, January 9). Clinical study of induced pluripotent stem cells derived motor neuron precursor cell therapy for amyotrophic lateral sclerosis (ALS) (iPSC-MNP). Identifier NCT06765564. https:\/\/clinicaltrials.gov\/study\/NCT06765564"},{"issue":"10494","key":"4820_CR150","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/S0140-6736(25)00513-6","volume":"405","author":"NA Shneider","year":"2025","unstructured":"Shneider NA, Harms MB, Korobeynikov VA, Rifai OM, Hoover BN, Harrington EA, et al. Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series. Lancet. 2025;405(10494):2075\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(25)00513-6.","journal-title":"Lancet"},{"key":"4820_CR151","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaf027","volume":"13","author":"S Wei","year":"2025","unstructured":"Wei S, Dong J, Hu Q, Bai J, Gao X, Shan H, et al. Advances in mesenchymal stem cells and their derivatives for promoting peripheral nerve regeneration. Burns Trauma. 2025;13:tkaf027. https:\/\/doi.org\/10.1093\/burnst\/tkaf027.","journal-title":"Burns Trauma"},{"key":"4820_CR152","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainresbull.2023.01.008","volume":"194","author":"F Sironi","year":"2023","unstructured":"Sironi F, De Marchi F, Mazzini L, Bendotti C. Cell therapy in ALS: an update on preclinical and clinical studies. Brain Res Bull. 2023;194:64\u201381. https:\/\/doi.org\/10.1016\/j.brainresbull.2023.01.008.","journal-title":"Brain Res Bull"},{"issue":"2","key":"4820_CR153","doi-asserted-by":"publisher","first-page":"868","DOI":"10.4049\/jimmunol.166.2.868","volume":"166","author":"D Skokos","year":"2001","unstructured":"Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, et al. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol. 2001;166(2):868\u201376. https:\/\/doi.org\/10.4049\/jimmunol.166.2.868.","journal-title":"J Immunol"},{"key":"4820_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00487","volume":"12","author":"D Sproviero","year":"2018","unstructured":"Sproviero D, La Salvia S, Giannini M, Crippa V, Gagliardi S, Bernuzzi S, et al. Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2018;12:487. https:\/\/doi.org\/10.3389\/fnins.2018.00487.","journal-title":"Front Neurosci"},{"key":"4820_CR155","unstructured":"Staff, N. P., & Mayo Clinic. (2017 \u2013 2026, March 9). Intrathecal autologous adipose-derived mesenchymal stromal cells for amyotrophic lateral sclerosis (ALS). Identifier NCT03268603. https:\/\/clinicaltrials.gov\/study\/NCT03268603"},{"issue":"21","key":"4820_CR156","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000003359","volume":"87","author":"NP Staff","year":"2016","unstructured":"Staff NP, Madigan NN, Morris J, Jentoft M, Sorenson EJ, Butler G, et al. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology. 2016;87(21):2230\u20134. https:\/\/doi.org\/10.1212\/WNL.0000000000003359.","journal-title":"Neurology"},{"issue":"9","key":"4820_CR157","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/mt.2010.105","volume":"18","author":"D Sun","year":"2010","unstructured":"Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18(9):1606\u201314. https:\/\/doi.org\/10.1038\/mt.2010.105.","journal-title":"Mol Ther"},{"issue":"3","key":"4820_CR158","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00441-014-1903-z","volume":"357","author":"H Sun","year":"2014","unstructured":"Sun H, Hou Z, Yang H, Meng M, Li P, Zou Q, et al. Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model. Cell Tissue Res. 2014;357(3):571\u201382. https:\/\/doi.org\/10.1007\/s00441-014-1903-z.","journal-title":"Cell Tissue Res"},{"issue":"8","key":"4820_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000689","volume":"2","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, et al. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE. 2007;2(8):e689. https:\/\/doi.org\/10.1371\/journal.pone.0000689.","journal-title":"PLoS ONE"},{"key":"4820_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15060601","author":"M Swash","year":"2025","unstructured":"Swash M, de Carvalho M. Dynamics of onset and progression in amyotrophic lateral sclerosis. Brain Sci. 2025. https:\/\/doi.org\/10.3390\/brainsci15060601.","journal-title":"Brain Sci"},{"key":"4820_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110760","volume":"202","author":"J Tang","year":"2023","unstructured":"Tang J, Kang Y, Zhou Y, Chen Q, Lan J, Liu X, et al. Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models. Brain Res Bull. 2023;202:110760. https:\/\/doi.org\/10.1016\/j.brainresbull.2023.110760.","journal-title":"Brain Res Bull"},{"key":"4820_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2282","volume":"3","author":"K Tang","year":"2012","unstructured":"Tang K, Zhang Y, Zhang H, Xu P, Liu J, Ma J, et al. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun. 2012;3:1282. https:\/\/doi.org\/10.1038\/ncomms2282.","journal-title":"Nat Commun"},{"issue":"7628","key":"4820_CR163","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197\u2013206. https:\/\/doi.org\/10.1038\/nature20413.","journal-title":"Nature"},{"issue":"165","key":"4820_CR164","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004579","volume":"4","author":"YD Teng","year":"2012","unstructured":"Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, et al. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci Transl Med. 2012;4(165):165ra164. https:\/\/doi.org\/10.1126\/scitranslmed.3004579.","journal-title":"Sci Transl Med"},{"issue":"6","key":"4820_CR165","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/mus.27724","volume":"66","author":"NJ Thakore","year":"2022","unstructured":"Thakore NJ, Lapin BR, Mitsumoto H, Pooled Resource Open-Access Als Clinical Trials Consortium. Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis. Muscle Nerve. 2022;66(6):702\u20138. https:\/\/doi.org\/10.1002\/mus.27724.","journal-title":"Muscle Nerve"},{"issue":"3","key":"4820_CR166","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1083\/jcb.147.3.599","volume":"147","author":"C Th\u00e9ry","year":"1999","unstructured":"Th\u00e9ry C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol. 1999;147(3):599\u2013610. https:\/\/doi.org\/10.1083\/jcb.147.3.599.","journal-title":"J Cell Biol"},{"key":"4820_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.875825","volume":"13","author":"AD Thome","year":"2022","unstructured":"Thome AD, Thonhoff JR, Zhao W, Faridar A, Wang J, Beers DR, et al. Extracellular vesicles derived from ex vivo expanded regulatory T cells modulate in vitro and in vivo inflammation. Front Immunol. 2022;13:875825. https:\/\/doi.org\/10.3389\/fimmu.2022.875825.","journal-title":"Front Immunol"},{"issue":"3","key":"4820_CR168","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.4081\/ejh.2024.4040","volume":"68","author":"E Turano","year":"2024","unstructured":"Turano E, Virla F, Scambi I, Dabrowska S, Bankole O, Mariotti R. Adipose mesenchymal stem cells-derived extracellular vesicles exert their preferential action in damaged central sites of SOD1 mice rather than peripherally. Eur J Histochem. 2024;68(3):4040. https:\/\/doi.org\/10.4081\/ejh.2024.4040.","journal-title":"Eur J Histochem"},{"key":"4820_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00407","volume":"14","author":"T Ueda","year":"2020","unstructured":"Ueda T, Inden M, Ito T, Kurita H, Hozumi I. Characteristics and therapeutic potential of dental pulp stem cells on neurodegenerative diseases. Front Neurosci. 2020;14:407. https:\/\/doi.org\/10.3389\/fnins.2020.00407.","journal-title":"Front Neurosci"},{"key":"4820_CR170","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-3-030-41283-8_11","volume":"1241","author":"EI Ustyantseva","year":"2020","unstructured":"Ustyantseva EI, Medvedev SP, Zakian SM. Studying ALS: current approaches, effect on potential treatment strategy. Adv Exp Med Biol. 2020;1241:195\u2013217. https:\/\/doi.org\/10.1007\/978-3-030-41283-8_11.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"4820_CR171","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","volume":"31","author":"A Vercelli","year":"2008","unstructured":"Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31(3):395\u2013405. https:\/\/doi.org\/10.1016\/j.nbd.2008.05.016.","journal-title":"Neurobiol Dis"},{"key":"4820_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100680","author":"EM Verde","year":"2025","unstructured":"Verde EM, Secco V, Ghezzi A, Mandrioli J, Carra S. Molecular mechanisms of protein aggregation in ALS-FTD: focus on TDP-43 and cellular protective responses. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14100680.","journal-title":"Cells"},{"key":"4820_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9070165","author":"J Wang","year":"2019","unstructured":"Wang J, Zuzzio K, Walker CL. Systemic dental pulp stem cell secretome therapy in a mouse model of amyotrophic lateral sclerosis. Brain Sci. 2019. https:\/\/doi.org\/10.3390\/brainsci9070165.","journal-title":"Brain Sci"},{"issue":"1","key":"4820_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00453-6","volume":"13","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang X, Yang Z, Wang B, Gong H, Zhang K, et al. Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases. Transl Neurodegener. 2024;13(1):60. https:\/\/doi.org\/10.1186\/s40035-024-00453-6.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"4820_CR175","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.celrep.2016.09.032","volume":"17","author":"T Westergard","year":"2016","unstructured":"Westergard T, Jensen BK, Wen X, Cai J, Kropf E, Iacovitti L, et al. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS\/FTD. Cell Rep. 2016;17(3):645\u201352. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.032.","journal-title":"Cell Rep"},{"issue":"1","key":"4820_CR176","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00665-w","volume":"18","author":"M Xie","year":"2023","unstructured":"Xie M, Pallegar PN, Parusel S, Nguyen AT, Wu LJ. Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms. Mol Neurodegener. 2023;18(1):75. https:\/\/doi.org\/10.1186\/s13024-023-00665-w.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"4820_CR177","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00415-019-09652-y","volume":"267","author":"L Xu","year":"2020","unstructured":"Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020;267(4):944\u201353. https:\/\/doi.org\/10.1007\/s00415-019-09652-y.","journal-title":"J Neurol"},{"issue":"7","key":"4820_CR178","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","volume":"82","author":"L Xu","year":"2006","unstructured":"Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation. 2006;82(7):865\u201375. https:\/\/doi.org\/10.1097\/01.tp.0000235532.00920.7a.","journal-title":"Transplantation"},{"key":"4820_CR179","doi-asserted-by":"publisher","unstructured":"Xu L, Shen P, Hazel T, Johe K, Koliatsos VE. Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci Lett. 2011;494(3):222-6. https:\/\/doi.org\/10.1016\/j.neulet.2011.03.017","DOI":"10.1016\/j.neulet.2011.03.017"},{"issue":"9","key":"4820_CR180","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1111\/cas.14563","volume":"111","author":"Z Xunian","year":"2020","unstructured":"Xunian Z, Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes. Cancer Sci. 2020;111(9):3100\u201310. https:\/\/doi.org\/10.1111\/cas.14563.","journal-title":"Cancer Sci"},{"key":"4820_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14020158","author":"K Yang","year":"2024","unstructured":"Yang K, Liu Y, Zhang M. The diverse roles of reactive astrocytes in the pathogenesis of amyotrophic lateral sclerosis. Brain Sci. 2024. https:\/\/doi.org\/10.3390\/brainsci14020158.","journal-title":"Brain Sci"},{"issue":"2","key":"4820_CR182","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1096\/fj.201800131RR","volume":"33","author":"J Yao","year":"2019","unstructured":"Yao J, Zheng J, Cai J, Zeng K, Zhou C, Zhang J, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. FASEB J. 2019;33(2):1695\u2013710. https:\/\/doi.org\/10.1096\/fj.201800131RR.","journal-title":"FASEB J"},{"key":"4820_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113414","volume":"333","author":"J Yelick","year":"2020","unstructured":"Yelick J, Men Y, Jin S, Seo S, Espejo-Porras F, Yang Y. Elevated exosomal secretion of miR-124-3p from spinal neurons positively associates with disease severity in ALS. Exp Neurol. 2020;333:113414. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113414.","journal-title":"Exp Neurol"},{"key":"4820_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082152","author":"R Younes","year":"2023","unstructured":"Younes R, Issa Y, Jdaa N, Chouaib B, Brugioti V, Challuau D, et al. The secretome of human dental pulp stem cells and its components GDF15 and HB-EGF protect amyotrophic lateral sclerosis motoneurons against death. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11082152.","journal-title":"Biomedicines"},{"issue":"1","key":"4820_CR185","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12951-023-01969-1","volume":"21","author":"L Yu","year":"2023","unstructured":"Yu L, Zhu G, Zhang Z, Yu Y, Zeng L, Xu Z, et al. Apoptotic bodies: bioactive treasure left behind by the dying cells with robust diagnostic and therapeutic application potentials. J Nanobiotechnol. 2023;21(1):218. https:\/\/doi.org\/10.1186\/s12951-023-01969-1.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"4820_CR186","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41419-019-1582-5","volume":"10","author":"C Zalfa","year":"2019","unstructured":"Zalfa C, RotaNodari L, Vacchi E, Gelati M, Profico D, Boido M, et al. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats. Cell Death Dis. 2019;10(5):345. https:\/\/doi.org\/10.1038\/s41419-019-1582-5.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4820_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01852-6","volume":"12","author":"P Zelina","year":"2024","unstructured":"Zelina P, de Ruiter AA, Kolsteeg C, van Ginneken I, Vos HR, Supiot LF, et al. ALS-associated C21ORF2 variant disrupts DNA damage repair, mitochondrial metabolism, neuronal excitability and NEK1 levels in human motor neurons. Acta Neuropathol Commun. 2024;12(1):144. https:\/\/doi.org\/10.1186\/s40478-024-01852-6.","journal-title":"Acta Neuropathol Commun"},{"key":"4820_CR188","doi-asserted-by":"publisher","unstructured":"Zhang LP, Liao JX, Liu YY, Luo HL, Zhang WJ. Potential therapeutic effect of olfactory ensheathing cells in neurological diseases: neurodegenerative diseases and peripheral nerve injuries. Front Immunol. 2023;14:1280186. https:\/\/doi.org\/10.3389\/fimmu.2023.1280186","DOI":"10.3389\/fimmu.2023.1280186"},{"key":"4820_CR189","doi-asserted-by":"publisher","unstructured":"Zhao CP, Zhang C, Zhou SN, Xie YM, Wang YH, Huang H, Shang YC, Li WY, Zhou C, Yu MJ, Feng SW. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy. 2007;9(5):414\u201326. https:\/\/doi.org\/10.1080\/14653240701376413","DOI":"10.1080\/14653240701376413"},{"issue":"5","key":"4820_CR190","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11684-021-0905-y","volume":"16","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, He L, Hu J, Gao Y, Shen D, Ni Y, et al. Increased expression of coronin-1a in amyotrophic lateral sclerosis: a potential diagnostic biomarker and therapeutic target. Front Med. 2022;16(5):723\u201335. https:\/\/doi.org\/10.1007\/s11684-021-0905-y.","journal-title":"Front Med"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04820-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04820-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:07:14Z","timestamp":1786975634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04820-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":190,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4820"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04820-2","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Application.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"401"}}